Discover Mirum Pharmaceuticals' Q1 2025 progress: 61% revenue growth, new drug approvals, and raised guidance.

Company on track to report interim biomarker data from the first 12 patients imminently Completion of patient enrollment and topline results expected Q3 2025 LA JOLLA, CA, May 07, 2025 (GLOBE NEWSWIRE ...

But she urged institutions to adopt a gradual approach to expanding enrollment, warning that rapid ... uncertainties for those planning to study abroad. "Parents and students are understandably ...

Female bonobos find strength in numbers, teaming up to fend off males in the wild, a new study finds. Along with chimpanzees, bonobos are among humans’ closest relatives. Scientists have long ...

“The study reinforces what public health has long suspected: More movement, in any form, seems to matter,” says Steven Quay, M.D., Ph.D., an experienced scientist-physician whose own research ...

“Male dominance is not evolutionarily inevitable,” said Harvard behavioral ecologist Martin Surbeck, who worked with Fruth on a study published Thursday in the journal Communications Biolog ...

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China Hong Kong, Shanghai & Florham Park, NJ - Tuesday, April 22, 2025: HUTCHMED ...

“We are pleased at the expanding patient enrollment in our Phase 3 study, and expect this to continue to grow,” stated Dr. William V. Williams, BriaCell’s President & CEO. “We believe our ...

HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that it has completed enrollment of ...

Such risks and uncertainties include, among other things, assumptions regarding enrollment rates and the timing and availability of subjects meeting a study's inclusion and exclusion criteria; changes ...

Such risks and uncertainties include, among other things, assumptions regarding enrollment rates and the timing and availability of subjects meeting a study’s inclusion and exclusion criteria ...

the completion of patient enrollment in its U.S. pivotal IDE clinical trial, MARRS ( Millipede Aspiration for Revascularization in Stroke Study), and 2) the appointment of seasoned medtech ...